GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sona Nanotech Inc (OTCPK:SNANF) » Definitions » ROE % Adjusted to Book Value

SNANF (Sona Nanotech) ROE % Adjusted to Book Value : -11.28% (As of Oct. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Sona Nanotech ROE % Adjusted to Book Value?

Sona Nanotech's ROE % for the quarter that ended in Oct. 2024 was -137.55%. Sona Nanotech's PB Ratio for the quarter that ended in Oct. 2024 was 12.19. Sona Nanotech's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2024 was -11.28%.


Sona Nanotech ROE % Adjusted to Book Value Historical Data

The historical data trend for Sona Nanotech's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sona Nanotech ROE % Adjusted to Book Value Chart

Sona Nanotech Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -53.16 -12.08

Sona Nanotech Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.99 -11.06 -5.80 - -11.28

Competitive Comparison of Sona Nanotech's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Sona Nanotech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sona Nanotech's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sona Nanotech's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Sona Nanotech's ROE % Adjusted to Book Value falls into.



Sona Nanotech ROE % Adjusted to Book Value Calculation

Sona Nanotech's ROE % Adjusted to Book Value for the fiscal year that ended in Oct. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-147.21% / 12.19
=-12.08%

Sona Nanotech's ROE % Adjusted to Book Value for the quarter that ended in Oct. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-137.55% / 12.19
=-11.28%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sona Nanotech ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Sona Nanotech's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Sona Nanotech Business Description

Traded in Other Exchanges
Address
1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and various biomedical applications. The company's product includes Gemini and Saliva tests.

Sona Nanotech Headlines

From GuruFocus